The Soy Isoflavones for Reducing Bone Loss (SIRBL) Study: a 3-y randomized controlled trial in postmenopausal women

被引:107
作者
Alekel, D. Lee [1 ]
Van Loan, Marta D.
Koehler, Kenneth J. [2 ]
Hanson, Laura N. [1 ]
Stewart, Jeanne W. [1 ]
Hanson, Kathy B. [1 ]
Kurzer, Mindy S. [3 ]
Peterson, C. Theodore [2 ]
机构
[1] Iowa State Univ, Nutr & Wellness Res Ctr, Dept Food Sci & Human Nutr, Ames, IA 50010 USA
[2] Iowa State Univ, Dept Stat, Ames, IA 50010 USA
[3] Univ Calif Davis, USDA, Agr Res Serv, Western Human Nutr Res Ctr, Davis, CA 95616 USA
关键词
ESTROGEN PLUS PROGESTIN; MINERAL DENSITY; DOUBLE-BLIND; PROTEIN ISOLATE; MENOPAUSAL SYMPTOMS; SERUM-LIPIDS; RISK; MASS; CONSUMPTION; CALCIUM;
D O I
10.3945/ajcn.2009.28306
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Our previous study indicated that soy protein with isoflavones lessened lumbar spine bone loss in midlife women. Objective: We examined the efficacy of isoflavones (extracted from soy protein) on bone mineral density (BMD) in nonosteoporotic postmenopausal women. We hypothesized that isoflavone tablets would spare BMD, with biological (age, body weight, serum 25-hydroxyvitamin D) and lifestyle (physical activity, dietary intake) factors modulating BMD loss. Design: Our double-blind, randomized controlled trial (36 mo) included healthy postmenopausal women (aged 45.8-65.0 y) with intent-to-treat (n = 224) and compliant (n = 208) analyses. Treatment groups consisted of a placebo control group and 2 soy isoflavone groups (80 compared with 120 mg/d); women received 500 mg calcium and 600 IU vitamin D3. Outcomes included lumbar spine, total proximal femur, femoral neck, and whole-body BMD. Results: Analysis of variance for intent-to-treat and compliant (>= 80%) models, respectively, showed no treatment effect for spine (P = 0.46, P = 0.21), femur (P = 0.86, P = 0.46), neck (P = 0.17, P = 0.14), or whole-body (P = 0.86, P = 0.78) BMD. From baseline to 36 mo, BMD declined regardless of treatment. In intent-to-treat and compliant models, respectively, BMD decreases were as follows: spine (-2.08%, -1.99%), femur (-1.43%, -1.38%), neck (-2.56%, -2.51%), and whole body (-1.66%, -1.62%). Regression analysis (compliant model) indicated that age, whole-body fat mass, and bone resorption were common predictors of BMD change. After adjustment for these factors, 120 mg (compared with placebo) was protective (P = 0.024) for neck BMD. We observed no treatment effect on adverse events, endometrial thickness, or bone markers. Conclusion: Our results do not show a bone-sparing effect of extracted soy isoflavones, except for a modest effect at the femoral neck. This trial was registered at clinicaltrials.gov as NCT00043745. Am J Clin Nutr 2010;91:218-30.
引用
收藏
页码:218 / 230
页数:13
相关论文
共 67 条
  • [1] Alekel DL, 2000, AM J CLIN NUTR, V72, P844
  • [2] ALEKEL DL, 1993, THESIS U ILLINOIS UR
  • [3] ALEKEL DL, 2006, HDB NUTRACEUTICALS F
  • [4] Ipriflavone in the treatment of postmenopausal osteoporosis - A randomized controlled trial
    Alexandersen, P
    Toussaint, A
    Christiansen, C
    Devogelaer, JP
    Roux, C
    Fechtenbaum, J
    Gennari, C
    Reginster, JY
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (11): : 1482 - 1488
  • [5] [Anonymous], 1999, Logistic regression using SAS: Theory and application
  • [6] One year soy protein supplementation has positive effects on bone formation markers but not bone density in postmenopausal women
    Arjmandi, Bahram H.
    Lucas, Edralin A.
    Khalil, Dania A.
    Devareddy, Latha
    Smith, Brenda J.
    McDonald, Jennifer
    Arquitt, Andrea B.
    Payton, Mark E.
    Mason, Claudia
    [J]. NUTRITION JOURNAL, 2005, 4 (1)
  • [7] Use of complementary and alternative medicine during the menopause transition: longitudinal results from the Study of Women's Health Across the Nation
    Bair, Yali A.
    Gold, Ellen B.
    Zhang, Guili
    Rasor, Niki
    Utts, Jessica
    Upchurch, Dawn M.
    Chyu, Laura
    Greendale, Gail A.
    Sternfeld, Barbara
    Adler, Shelley R.
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (01): : 32 - 43
  • [8] Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women
    Beresford, SAA
    Weiss, NS
    Voigt, LF
    McKnight, B
    [J]. LANCET, 1997, 349 (9050) : 458 - 461
  • [9] Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P1253
  • [10] RELATIONSHIP OF ANIMAL PROTEIN-RICH DIET TO KIDNEY-STONE FORMATION AND CALCIUM-METABOLISM
    BRESLAU, NA
    BRINKLEY, L
    HILL, KD
    PAK, CYC
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 66 (01) : 140 - 146